Business Context and Reporting Period
This Form 6-K filing by Midatech Pharma PLC (noted as Biodexa Pharmaceuticals Plc in metadata) covers the month of September 2021. The filing incorporates by reference a press release dated September 17, 2021, detailing interim results for the six months ended June 30, 2021.
Key Financial Metrics
The provided text contains only the cover page and exhibit index of the Form 6-K. It does not include the actual financial data from the incorporated press release. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
The filing text does not provide comparative financial data or details regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
Management commentary, future guidance, risk factors, contingencies, and unusual items are not detailed in the provided text, as the substantive content is located in the referenced Exhibit 99.1 which is not included in the input.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name ("Biodexa Pharmaceuticals Plc") and the registrant name on the form ("Midatech Pharma PLC").
- Access Exhibit 99.1 (Press Release dated September 17, 2021) to obtain actual interim financial results for the six months ended June 30, 2021.
- Confirm the company's current operational status and any potential name changes or corporate restructuring.